International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of the rheumatic diseases, vol.73, pp.17-23, 2013. ,
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing, Arthritis and rheumatism, vol.47, issue.4, pp.434-478, 2002. ,
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis, Journal of autoimmunity, vol.34, issue.1, pp.55-63, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01163300
Autoantibodies in interstitial cystitis. The Journal of urology, vol.151, pp.587-92, 1994. ,
LEDGF (p75) promotes DNA-end resection and homologous recombination, Nature structural & molecular biology, vol.19, issue.8, pp.803-813, 2012. ,
Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort, Clinical & developmental immunology, p.703759, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01548814
, , p.3580898
Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions, The Journal of allergy and clinical immunology, vol.105, issue.6, pp.1211-1231, 2000. ,
Autoantibodies to DFS70/ LEDGF are increased in alopecia areata patients, Journal of autoimmunity, vol.23, issue.3, pp.257-66, 2004. ,
Journal of ocular pharmacology and therapeutics: the official journal of the Association for, Ocular Pharmacology and Therapeutics, vol.16, issue.2, pp.181-91, 2000. ,
Humoral immune response directed against LEDGF in patients with VKH, Immunology letters, vol.78, issue.3, pp.161-169, 2001. ,
Anti-DFS70 antibodies in 597 healthy hospital workers, Arthritis and rheumatism, vol.50, issue.3, pp.892-900, 2004. ,
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases, Epub 2010/10/19, vol.63, pp.191-200, 2011. ,
, National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing. London: Royal College of Physicians (UK)National Clinical Guideline Centre, 2012.
Range of antinuclear antibodies in "healthy" individuals. Arthritis and rheumatism, vol.40, pp.1601-1612, 1997. ,
The mutation Ala677->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis, Thrombosis and haemostasis, vol.77, issue.5, pp.818-839, 1997. ,
Mutations in coagulation factors in women with unexplained late fetal loss, The New England journal of medicine, vol.343, issue.14, pp.1015-1023, 2000. ,
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, issue.10, pp.3698-703, 1996. ,
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England journal of medicine, vol.332, pp.912-919, 1995. ,
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. The New England journal of medicine, vol.341, pp.801-807, 1999. ,
Increased frequency of genetic thrombophilia in women with complications of pregnancy. The New England journal of medicine, vol.340, pp.9-13, 1999. ,
Increased fetal loss in women with heritable thrombophilia, Lancet, vol.348, issue.9032, pp.913-919, 1996. ,
Epitope specificity and significance in systemic autoimmune diseases, Annals of the New York Academy of Sciences, vol.1183, pp.267-87, 2010. ,
A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders, Autoimmunity reviews, vol.7, issue.1, pp.77-84, 2007. ,
Clinical aspects of autoimmune rheumatic diseases, Lancet, vol.382, issue.9894, pp.797-808, 2013. ,
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), JTH, vol.4, issue.2, pp.295-306, 2006. ,
A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism, Blood, vol.104, issue.12, pp.3631-3635, 2004. ,
A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thrombosis research, vol.129, pp.8-13, 2012. ,
American journal of obstetrics and gynecology, vol.191, pp.412-436, 2004. ,
Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation, The EMBO journal, vol.17, issue.22, pp.6723-6732, 1998. ,
Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses, vol.40, pp.1444-51, 1999. ,
Significance of heparin binding to basic residues in homologous to the amino terminus of hepatoma-derived growth factor and related proteins, Glycobiology, vol.22, issue.5, pp.649-61, 2012. ,
Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus, Investigative ophthalmology & visual science, vol.41, issue.9, pp.2648-57, 2000. ,
The antiphospholipid syndrome. The New England journal of medicine, vol.346, pp.752-63, 2002. ,
Heparin-induced thrombocytopenia: a historical perspective, Blood, vol.112, issue.7, pp.2607-2623, 2008. ,
Heparin-induced thrombocytopenia in cardiovascular patients: pathophysiology, diagnosis, and treatment, Cardiology in review, vol.19, issue.3, pp.143-53, 2011. ,
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis and rheumatism, vol.48, issue.10, pp.2741-2750, 2003. ,
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children, Jama, vol.309, issue.23, pp.2473-2482, 2013. ,
Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England journal of medicine, vol.349, pp.1526-1559, 2003. ,
Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain, Journal of autoimmunity, vol.23, issue.3, pp.221-252, 2004. ,